1. Application and feasibility of systemic lupus erythematosus reproductive health care quality indicators at a public urban rheumatology clinic. (February 2015) Authors: Quinzanos, I; Davis, L; Keniston, A; Nash, A; Yazdany, J; Fransen, R; Hirsh, J M; Zell, J Journal: Lupus Issue: Volume 24:Number 2(2015) Page Start: 203 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Discussing sudden unexpected death in epilepsy: Are we empowering our patients? A questionnaire survey. (August 2016) Authors: Keddie, S; Angus-Leppan, H; Parker, T; Toescu, S; Nash, A; Adewunmi, O; Liu, RSN Journal: JRSM open Issue: Volume 7:Number 9(2016:Sep.) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Preclinical characterisation of the GM-CSF receptor as a therapeutic target in rheumatoid arthritis. Issue 10 (16th June 2014) Authors: Greven, D E A; Cohen, E S; Gerlag, D M; Campbell, J; Woods, J; Davis, N; van Nieuwenhuijze, A; Lewis, A; Heasmen, S; McCourt, M; Corkill, D; Dodd, A; Elvin, J; Statache, G; Wicks, I P; Anderson, I K; Nash, A; Sleeman, M A; Tak, P P Journal: Annals of the rheumatic diseases Issue: Volume 74:Issue 10(2015) Page Start: 1924 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Protein engineering and preclinical development of a GM‐CSF receptor antibody for the treatment of rheumatoid arthritis. (18th December 2012) Authors: Minter, RR; Cohen, ES; Wang, B; Liang, M; Vainshtein, I; Rees, G; Eghobamien, L; Harrison, P; Sims, DA; Matthews, C; Wilkinson, T; Monk, P; Drinkwater, C; Fabri, L; Nash, A; McCourt, M; Jermutus, L; Roskos, L; Anderson, IK; Sleeman, MA Journal: British journal of pharmacology Issue: Volume 168:Number 1(2013:Jan.) Page Start: 200 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Protein engineering and preclinical development of a GM‐CSF receptor antibody for the treatment of rheumatoid arthritis. (18th December 2012) Authors: Minter, RR; Cohen, ES; Wang, B; Liang, M; Vainshtein, I; Rees, G; Eghobamien, L; Harrison, P; Sims, DA; Matthews, C; Wilkinson, T; Monk, P; Drinkwater, C; Fabri, L; Nash, A; McCourt, M; Jermutus, L; Roskos, L; Anderson, IK; Sleeman, MA Journal: British journal of pharmacology Issue: Volume 168:Number 1(2013:Jan.) Page Start: 200 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Recovery of Microbial Contamination with Settle Plates Exposed in a Unidirectional Airflow Workstation for 4 Hours. Issue 1 (2022) Authors: Eaton, T; Capper, K; Nash, A; Drinkwater, S; Bright, J Journal: European journal of parenteral & pharmaceutical sciences Issue: Volume 27:Issue 1(2022) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. The Distribution and Possible Roles of Small Cardioactive Peptide in the Nudibranch Melibe leonina. Issue 1 (29th May 2020) Authors: Watson, W H; Nash, A; Lee, C; Patz, M D; Newcomb, J M Journal: Integrative organismal biology Issue: Volume 2:Issue 1(2020) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗